Healthsens develops enzymatic and immunological biosensors, creating self-test and POCT (Point of Care Testing) devices for the diagnosis and monitoring of the major impact diseases affecting the worldwide population.


Self-test device.
Enzymatic biosensor designed for the quantification of creatinine level in peripheral blood and estimation of the glomerular filtration rate (eGFR), making possible to have a comprehensive control over kidney disease, which is considered the third impact disease across the world.



POCT device for the early detection of prostate cancer (prostate health index PHI).
Bio-immunosensor that will analyze the biomarkers associated with prostate cancer with a single drop of patient’s serum. For the construction of these HEALTHSENS sensors a completely new methodology is being developed based on the use of magnetic nanoparticles.


Diagnosis of myocardial infarction.
Healthsens is currently developing a useful rapid test for the specific and early diagnosis of myocardial infarction. Using a lateral flow strip, patients will be able to know quickly if they are having a heart attack.


Need more information?
Ask us!

Do not hesitate to contact us to request more information about HEALTHSENS.

(+34) 985 232 428